FdaApplication
ANDA 211966
Identifiers
- fda_app_no: ANDA211966
Properties
| Property | Value |
|---|---|
| applicant_name | BAXTER HEALTHCARE CORP |
| application_type | ANDA |
| approval_date | 2020-06-01 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MAGNESIUM SULFATE | MAGNESIUM SULFATE | 3GM/100ML (30MG/ML) | INJECTABLE;INJECTION |
| MAGNESIUM SULFATE IN PLASTIC CONTAINER | MAGNESIUM SULFATE | 4GM/50ML (80MG/ML) | INJECTABLE;INJECTION |
| MAGNESIUM SULFATE IN PLASTIC CONTAINER | MAGNESIUM SULFATE | 4GM/100ML (40MG/ML) | INJECTABLE;INJECTION |
| MAGNESIUM SULFATE IN PLASTIC CONTAINER | MAGNESIUM SULFATE | 2GM/50ML (40MG/ML) | INJECTABLE;INJECTION |
4 products